The effect of the cholinesterase inhibitor donepezil on organic and functional deficits related to growth hormone deficiency in old age.
- Conditions
- We plan to study healthy aging subjects.
- Registration Number
- EUCTR2005-001315-22-AT
- Lead Sponsor
- udwig Boltzmann Gesellschaft
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Healthy aging women and men aged 70 to 75 years.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Sick sinus syndrome, atrioventricular block, sinuatrial block
Asthma brochiale, COPD
Gastric or duodenal ulcers
Urinary obstruction
Severe renal or hepatic impairment
Known hypersensitivity against the investigational drug
Medication with beta-blockers, cholinomemetica or NSAIDs
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method